Critical Care Flashcards
What defines shock?
Shock is a clinical condition in which there is inadequate tissue perfusion and oxygenation to end organs such as the brain, heart, liver, kidneys, and abdominal viscera. Early in its course, shock may be reversible, but ongoing shock results in multiorgan system failure and ultimately death. (673)
List three major categories of shock. How can they be differentiated using central venous pressure (CVP) and cardiac output (CO) measurements?
○ The major categories of shock include hypovolemic, cardiogenic, and septic (or other forms of vasodilatory shock).
○ In hypovolemic shock, both CO and CVP are reduced due to decreased venous return.
○ In contrast, cardiogenic shock is typified by a decrease in CO due to poor pump function, but CVP is usually increased.
○ Finally, in septic shock, CVP is usually decreased due to profound vasodilation and pooling of blood in the splanchnic beds, but CO is typically increased in early sepsis. However, CO may be normal or even depressed in later more advanced septic shock. (673, Table 41-5)
What are some common causes of hypovolemic shock?
The most common cause of hypovolemic shock is major blood loss, as can occur in trauma, surgery, or with massive gastrointestinal hemorrhage.
What are the common clinical findings of hypovolemic shock?
○ Hypovolemic shock is caused by inadequate circulating blood volume, and therefore decreased preload and cardiac output.
○There is usually a baroreceptormediated reflex tachycardia and an increase in systemic vascular resistance.
○ Gluconeogenesis is induced, as is sodium reabsorption from the kidneys. ○ In addition to being hypotensive, the patient may appear cool, clammy, and pale with increased plasma glucose levels and decreased urine output. (673)
What is the treatment for hypovolemic shock?
○ The treatment for hypovolemic shock requires adequate intravenous access and aggressive fluid therapy to restore circulating blood volume.
○ Fluid resuscitation can beguidedbytheuseofacentral venous monitor or arterial blood pressure variation, as well as laboratory analysis of metabolic variables.
○ Vasopressor therapy can be used to increase systemic blood pressure, but is generally not effective until circulating blood volume is restored.
What are the causes of cardiogenic shock?
○ Cardiogenic shock occurs when the heart is not able to pump an adequate cardiac output.
○ The most common cause of cardiogenic shock is myocardial infarction.
○ Other causes include severe myocarditis, endocarditis, or a tear or rupture of a portion of the heart.
○ If the right ventricle is the initial site of failure, the increased right-sided preload will be noted as increased CVP, detected clinically as distended neck veins, peripheral edema, or hepatic congestion.
○ If the left ventricle fails, the increased preload can be detected as increased pulmonary capillary wedge pressure, which causes cardiogenic pulmonary edema and rales on physical examination.
○ In either scenario, cardiac output is low, and systemic blood pressure is therefore reduced.
○ On physical examination, a patient in cardiogenic shock appears cool and pale secondary to the high systemic vascular resistance and shunting of blood away from the skin and skeletal muscle beds
Cardiogenic shock treatment
○ The goal for treatment of cardiogenic shock is to improve cardiac output and decrease afterload to reduce myocardial demand.
○ Resuscitation should be guided by the use of central venous monitors, direct arterial blood pressure measurements, and echocardiography. ○ Vasodilator therapy can be used to reduce preload and afterload.
○ Dobutamine therapy may also be useful. Treatment with diuretics must be done with extreme caution.
○ In cardiogenic shock refractory to treatment an intraaortic balloon counterpulsation (IABP) or ventricular assist device (VAD) may be indicated.
What are the common clinical findings of vasodilatory shock?
Intheinitialstagesofvasodilatoryshockanincreaseincardiacoutputmaycompensate for the decrease in systemic vascular resistance and the patient may appear warmand vasodilated. With worsening metabolic acidosis myocardial perfusion becomes impaired, and the patient will become increasingly cool and clammy. (
What is the treatment for vasodilatory shock?
The treatment for vasodilatory shock involves adequate fluid volume resuscitation in conjunction with possible vasopressor therapy. The underlying cause of the disorder should also be treated. In septic shock early identification of the source of the infection and treatment with broad-spectrum antibiotics is necessary. (674-675
Upon which receptor subtypes does dopamine have agonist activity?
Dopamine has both direct and indirect agonist activity at the dopamine1 (DA1), b1,anda1receptors.Itspharmacologicactionvarieswithdoseandwithinindividuals. At low doses (0 to 5 mg/kg/min), dopamine has predominantly DA1 receptor agonist activity. This causesdilation of therenalarteriolesandpromotesdiuresis.Atmoderate doses (5 to 10 mg/kg/min), the b-effects of dopamine begin to dominate. These b1effects cause anincreaseinmyocardialcontractility, heart rate, and cardiacoutput. At highdoses(10to20 mg/kg/min),thea1-agonisteffectspredominateanddopamineacts toincreasevascularsmoothmuscletone,whichincreasessystemicvascularresistance. Thiscausesadecreaseinsplanchnicandrenalbloodflowsimilartotheeffectsofhighdose phenylephrine.
Upon which receptor subtypes does epinephrine have agonist activity?
Epinephrine causes direct stimulation of a1, b1, and b2 receptors. At lower doses, epinephrine acts primarily as a b receptor agonist, whereas at higher doses, it has increasing a1 receptor effects. Increases in heart rate, myocardial activity, and cardiac output reflect b1 receptor effects. The principal b2-effects are bronchial and vascular smooth muscle relaxation. At higher doses, the a1-effects of epinephrine act to increase systemic vascular resistance and reduce splanchnic and renal blood flow while maintaining both cerebral and myocardial perfusion pressure.
Upon which receptor subtypes does epinephrine have agonist activity?
Epinephrine causes direct stimulation of a1, b1, and b2 receptors. At lower doses, epinephrine acts primarily as a b receptor agonist, whereas at higher doses, it has increasing a1 receptor effects. Increases in heart rate, myocardial activity, and cardiac output reflect b1 receptor effects. The principal b2-effects are bronchial and vascular smooth muscle relaxation. At higher doses, the a1-effects of epinephrine act to increase systemic vascular resistance and reduce splanchnic and renal blood flow while maintaining both cerebral and myocardial perfusion pressure.
What are the advantages of norepinephrine use in septic shock?
Norepinephrine is a direct-acting adrenergic agonist with activity at both the a1 andb1receptors. As a result, norepinephrine increases blood pressure through its a1-effects on increasing systemic vascular resistance. The b1-effects of norepinephrine also contribute to increased myocardial contractility and cardiac output. There has been renewed interest in norepinephrine specifically for the treatment of septic shock. It is thought that this b1-activity may help offset the myocardial dysfunction associated with severe sepsis and septic shock. Both preclinical and limited clinical data suggest that norepinephrine is the pressor of choice for patients in septic shock
Upon which receptor does phenylephrine have agonist activity?
Phenylephrine is a direct-acting, highly selective a1 receptor agonist which increases systemic vascular resistance and arterial blood pressure. Phenylephrine can cause a reflex bradycardia, which can decrease cardiac output. Phenylephrine can be used to increase systemic vascular resistance in shock, but in high doses higher than 200 mg/min it has little additional therapeutic effect and may cause splanchnic ischemia.
What are the hemodynamic effects of dobutamine infusion?
○ Dobutamine is a mixed b1 and b2 receptor agonist.
○ As a result, the primary effect of dobutamine is to increase both heart rate and myocardial contractility.
○ Dobutamine also relaxes vascular smooth muscle via binding at b2 receptors.
○ This combination acts to increase cardiac output by improving ventricular function (b1-effect) and decreasing systemic vascular resistance (b2-effect).
○ Because of its b2-effects, some patients may become hypotensive, particularly those with decreased intravascular volume.
How does vasopressin differ in its mechanism of action when compared to norepinephrine
Vasopressin is a potent vasoconstrictor that does not work via the adrenergic receptor system as do most other vasopressors and inotropes. Rather, vasopressin binds to peripheral vasopressin receptors to induce potent vasoconstriction via phosphodiesterase inhibition. In contrast to norepinephrine, vasopressin has no intrinsic inotropic effects. However, vasopressin remains efficacious as a vasoconstrictor even in the setting of severe acidosis. As such vasopressin may provide a useful alternative to catecholamines, which do not function well in the setting of profound acidemia. (676)
The most common cause of vasodilatory shock is sepsis. Other causes of vasodilatory shock include anaphylaxis, stroke, and spinal shock as from a high spinal cord injury. Vasodilatory shock is also the final common pathway for late-shock stages of cardiogenic and hypovolemic shock.
List the typical indications formechanical ventilation in the ICU
○ Mechanical ventilatory support is typically initiated for the treatment of respiratory failure due to impaired oxygenation, impaired carbon dioxide excretion(ventilatory failure), and airway protection.
○ Patients receive mechanical ventilatorysupport to
(1) reduce the work of breathing,
(2) reverse progressive respiratoryacidosis or hypoxemia,
(3) reduce the risk for aspiration, or
(4) ensure a patentairway with severe neck and facial swelling or trauma. (
What are some common causes of respiratory failure
Common causes of respiratory failure may include trauma, ARDS, sepsis,
pneumonia, and cardiogenic and noncardiogenic pulmonary edema.
What are some common causes of ventilatory failure
Ventilatory failure may be due to chronic obstructive pulmonary disease (COPD), asthma, and/or drug intoxication.
What are some indications for the need for airway protection
Airway protection indications are usually limited to conditions such as altered
mental status, head and neck trauma or swelling, or significant neuromuscular disorders.
What are some common modes of mechanical ventilation
Common modes of mechanical ventilation include continuous mandatory ventilation, synchronized intermittent mandatory ventilation, pressure support ventilation, and PEEP.
Describe the key ventilatory settings in continuous mandatory ventilation(CMV) mode.
In CMV mode, the ventilator is programmed to deliver a set tidal volume at a set respiratory rate, thereby resulting in the delivery of a predictable minute ventilation. The ventilator will deliver its preset tidal volume at its preset time.
How can the inspiratory and expiratory time be adjusted in CMV mode?
○ To regulate the amount of time that the ventilator spends cycling in inspirationand expiration, the inspiratory flow rate is set.
○ By increasing inspiratory flow,
the set tidal volume is delivered in a shorter time, which allows more time
for exhalation.
What effect does a patient’s breathing effort have when mechanically ventilated inCMV mode?
The patient’s breathing efforts are unsupported in CMV mode. The ventilator continues to deliver its preset tidal volume at its preset time regardless of patient effort.